search
stem cell therapy
Trends
- 1Study Outlines New Framework for Direct Cell Reprogramming▼Study outlines a new framework for direct cell reprogramming
Researchers at Michigan Medicine have published a study presenting a new framework for direct cell reprogramming, the process of converting one cell type into another without passing through a stem cell state. The work could guide future regenerative medicine approaches by clarifying how cell identity can be changed. Details of the findings and their practical implications are still limited in early coverage.
- 2
Researchers report that artificial intelligence can distinguish between aged and young stem cells, a finding highlighted in a new science news release. If confirmed, the method could help scientists understand how ageing affects regenerative capacity and support therapies that rely on healthy stem cells. Details of the study team and the underlying research remain limited in the available information.
- 3EU approves NEZGLYAL, first drug for childhood cerebral ALD▼European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD
The European Commission has granted marketing authorisation for NEZGLYAL, the first pharmacological treatment for childhood cerebral adrenoleukodystrophy (cALD), a rare and severe genetic brain disorder. Until now, treatment options were largely limited to stem cell transplantation and supportive care. The approval offers a new therapy option for patients across the EU and is being noted in rare disease and biotech circles.
- 4Japanese hospital performs world's first heart stem cell sheet surgery▼A hospital in Japan has carried out the world's first surgery using sheets of commercially available heart muscle stem c
A hospital in Japan has performed the world's first surgery using sheets of commercially available heart muscle stem cells, according to one of the surgeons involved. The groundbreaking therapy was approved earlier this year, and this operation marks the first time the ready-made cell sheets have been used in a patient. The procedure is being seen as a significant step for regenerative medicine in treating heart disease.
- 5
New research indicates stem cells can withstand the harsh conditions of spaceflight better than expected, surviving the vibrations, radiation and microgravity experienced during launch and travel. The findings suggest that regenerative therapies and cell-based treatments may remain viable on long-duration space missions, with implications for astronaut health care and potential medical manufacturing in orbit.
- 6
Stat News asks whether stem cell treatments are finally poised to become a mainstream medical reality. The piece fuels renewed debate about how close regenerative medicine is to delivering proven therapies, a question that has long drawn both scientific interest and controversy over unproven clinics. Researchers, patient advocates and regulators continue to spar over the evidence base and what standards should govern any wider rollout.
- 7QC6352 found to target DHODH in glioblastoma stem cells▼DHODH is the key target of the KDM4 inhibitor QC6352 in glioblastoma stem cells
New research indicates that QC6352, developed as a KDM4 inhibitor, acts primarily on DHODH, an enzyme involved in pyrimidine synthesis, when attacking glioblastoma stem cells. The finding reshapes understanding of how the compound kills these treatment-resistant cells and could guide future drug design for an aggressive brain cancer with few effective options. Researchers and oncology watchers are weighing the implications for therapy development.
- 8Systematic Review Examines Stem Cell Therapy for Hearing Restoration▼Integrating Regenerative Medicine and Stem Cell Therapy in Hearing Restoration: A Systematic Review
A systematic review published in Cureus examines the integration of regenerative medicine and stem cell therapy in restoring hearing. The review assesses current research on whether stem cell-based approaches can repair damaged inner ear structures and recover hearing function, summarising available evidence on progress and remaining limitations in this emerging field of treatment.
- 9Stem cell advocates see an opening under RFK Jr.●Are stem cells the next peptides? These advocates think RFK Jr. could make it happen
Advocates for stem cell therapies are betting that Health and Human Services Secretary Robert F. Kennedy Jr. could loosen regulation of the field, drawing a parallel to the surge in popularity of peptide treatments. They hope policy changes under his leadership would make stem cell treatments more widely available, though mainstream scientists remain wary about unproven claims and safety risks.